Cargando…
Randomized, Controlled, Multi-center Trial: Comparing the Safety and Efficacy of DA-9701 and Itopride Hydrochloride in Patients With Functional Dyspepsia
BACKGROUND/AIMS: Therapies of functional dyspepsia (FD) are limited. DA-9701 is a novel prokinetic agent formulated with Pharbitis semen and Corydalis Tuber. We aimed to assess the efficacy of DA-9701 compared with itopride in FD patients. METHODS: Patients with FD randomly received either itopride...
Autores principales: | Choi, Myung-Gyu, Rhee, Poong-Lyul, Park, Hyojin, Lee, Oh Young, Lee, Kwang Jae, Choi, Suck Chei, Seol, Sang Young, Chun, Hoon Jai, Rew, Jong-Sun, Lee, Dong Ho, Song, Geun Am, Jung, Hwoon Yong, Jeong, Hyung Yong, Sung, In Kyung, Lee, Joon Seong, Lee, Soo Teik, Kim, Sung Kook, Shin, Yong Woon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Neurogastroenterology and Motility
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496904/ https://www.ncbi.nlm.nih.gov/pubmed/26130637 http://dx.doi.org/10.5056/jnm14117 |
Ejemplares similares
-
Efficacy of DA-9701 (Motilitone) in Functional Dyspepsia Compared to Pantoprazole: A Multicenter, Randomized, Double-blind, Non-inferiority Study
por: Jung, Hye-Kyung, et al.
Publicado: (2016) -
Effect of DA-9701 on Colorectal Distension-Induced Visceral Hypersensitivity in a Rat Model
por: Kim, Eun Ran, et al.
Publicado: (2014) -
DA-9701: A New Multi-Acting Drug for the Treatment of Functional Dyspepsia
por: Kwon, Yong Sam, et al.
Publicado: (2013) -
Evaluation of the Efficacy and Safety of DA-9601 versus Its New Formulation, DA-5204, in Patients with Gastritis: Phase III, Randomized, Double-Blind, Non-Inferiority Study
por: Choi, Yoon Jin, et al.
Publicado: (2017) -
Nitrergic Pathway Is the Major Mechanism for the Effect of DA-9701 on the Rat Gastric Fundus Relaxation
por: Min, Yang Won, et al.
Publicado: (2014)